Literature DB >> 23381031

Clinical guidelines: blood pressure goals in T2DM: a Latin American perspective.

George Bakris.   

Abstract

Mesh：

Year:  2013        PMID： 23381031     DOI： 10.1038/nrendo.2013.28

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE.

Authors:  John Chalmers; Hisatomi Arima
Journal:  J Cardiovasc Pharmacol       Date:  2010-04       Impact factor: 3.105

2.  ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.

Authors:  Robert O Bonow; Pamela S Douglas; Alfred E Buxton; David J Cohen; Jeptha P Curtis; Elizabeth Delong; Joseph P Drozda; T Bruce Ferguson; Paul A Heidenreich; Robert C Hendel; Frederick A Masoudi; Eric D Peterson; Allen J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-08-29       Impact factor: 24.094

3.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

4.  Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden J Manns; Scott Klarenbach; Neesh Pannu; Matthew T James; Brenda R Hemmelgarn
Journal:  Lancet       Date:  2012-06-19       Impact factor: 79.321

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

Authors:  Rhonda M Cooper-DeHoff; Yan Gong; Eileen M Handberg; Anthony A Bavry; Scott J Denardo; George L Bakris; Carl J Pepine
Journal:  JAMA       Date:  2010-07-07       Impact factor: 56.272

7.  Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome.

Authors:  Patricio López-Jaramillo; Ramiro A Sánchez; Margarita Diaz; Leonardo Cobos; Alfonso Bryce; Jose Z Parra Carrillo; Fernando Lizcano; Fernando Lanas; Isaac Sinay; Iván D Sierra; Ernesto Peñaherrera; Mario Bendersky; Helena Schmid; Rodrigo Botero; Manuel Urina; Joffre Lara; Milton C Foss; Gustavo Márquez; Stephen Harrap; Agustín J Ramírez; Alberto Zanchetti
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

Review 8.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Authors:  Bakhtawar K Mahmoodi; Kunihiro Matsushita; Mark Woodward; Peter J Blankestijn; Massimo Cirillo; Takayoshi Ohkubo; Peter Rossing; Mark J Sarnak; Bénédicte Stengel; Kazumasa Yamagishi; Kentaro Yamashita; Luxia Zhang; Josef Coresh; Paul E de Jong; Brad C Astor
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

Review 9.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Authors:  Caroline S Fox; Kunihiro Matsushita; Mark Woodward; Henk J G Bilo; John Chalmers; Hiddo J Lambers Heerspink; Brian J Lee; Robert M Perkins; Peter Rossing; Toshimi Sairenchi; Marcello Tonelli; Joseph A Vassalotti; Kazumasa Yamagishi; Josef Coresh; Paul E de Jong; Chi-Pang Wen; Robert G Nelson
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

10.  Summary of revisions for the 2013 clinical practice recommendations.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.